Backed by global investor syndicate led by new investors Farallon Capital Management and Lauxera Capital Partners along with Softbank Fund 2, funds and accounts advised by T. Rowe Price Associates, Parian Global Management, Gilde Healthcare, Pura Vida Investments, and Irving Investors. Amsterdam, the Netherlands – LUMICKS, a leading, next generation life science tools company that develops […]
SAN DIEGO — Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures. In addition LYFE Capital has joined the syndicate. The proceeds of the financing will be used to advance the company’s proprietary […]
Led by Sequoia, new funding will fuel life sciences cloud leader’s global growth and product expansion SAN FRANCISCO — Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital and Elad Gil. Existing investors participated, including Thrive […]
Funding will accelerate company growth and infrastructure expansion leading up to full commercial launch Vizgen, the life science company dedicated to advancing human health by visualizing single-cell spatial genomics information, has closed a $37 million Series B financing. The financing was co-led by Novalis LifeSciences LLC, and current investor Northpond Ventures. Also participating in the round were […]
CDD Awarded $1.5M Phase 2 SBIR Grant on an Intelligent Chemical Structure Browser for Drug Discovery and Optimization Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer-reviewed Phase 2 SBIR grant from NIH NCATS, titled: “Intelligent Chemical Structure Browser for Drug Discovery and Optimization”. This […]
GeneMill at the University of Liverpool receives first benchtop Onyx platform in Europe Financing round led by Fidelity and T. Rowe Price funds underscores vast opportunities to bring Inscripta’s CRISPR-based technology to the broader bioeconomy Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyx™ platform and the closing of […]
The Swedish AI software company Qlucore AB (“Qlucore” or “the Company”) – with more than 200 international customers – today announces that it has secured SEK 30 million before transaction costs in a pre-IPO private placement. The raised capital will predominantly be used to accelerate sales activities and expand the technical team prior to an […]
Partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics ‘s-Hertogenbosch (The Netherlands) – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME […]
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore”) has today announced that it has informed its shareholders that it has started the process of preparing for a potential Initial Public Offering (“IPO”). Whilst the timing of a potential […]
Transaction combines SomaLogic’s comprehensive proteomics technology platform with CM Life Sciences II, a leading life science-focused SPAC, led by affiliates of institutional investors Casdin Capital and Corvex Management. Combination is expected to provide up to $651 million in cash proceeds for SomaLogic, expanding the cash on its balance sheet to $686 million to catalyze organic […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
